Introduction and Context
Clinical practice recommendations and points-to-consider (PtCs) are central tools that translate research into everyday decisions for people living with rheumatic and musculoskeletal diseases (RMDs). The European Alliance of Associations for Rheumatology (EULAR) has long published guidance used worldwide by rheumatologists, allied health professionals, patients and policy makers. In 2026 EULAR released an updated standardised operating procedure (SOP) describing how recommendations and PtCs for diagnosis and management of RMDs should be developed, reported and updated [1].
